As an engineer, Melinda Decker could have designed widgets or Styrofoam cups or even gone into winemaking. But her passion for improving patient outcomes led her to digital therapeutics, and eventually to Mymee, a direct-to-consumer platform that helps people with autoimmune disorders manage their symptoms.
Mymee recognizes that behavior change is hard, so they combine a user-friendly app and data analytics with health coaching, to help users identify their triggers and make long-lasting lifestyle changes that lessen the severity of their symptoms and improve their overall health. Since its founding in 2017, Mymee has collaborated on two publications and recently closed a funding round of $8.7 million.
Join Eugene and Melinda’s conversation about digital therapeutics vs. disease management and the path the Mymee team took to getting their solution off the ground.
>>Click here to read the transcript
Guest Links and Resources:
Connect with Melinda Decker: LinkedIn
Visit Mymee: Twitter | LinkedIn | Facebook | Website
Host Links and Resources:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Follow Eugene's journey of writing his first book: Hard Pill to Swallow
Connect with YourCoach.health: Website | Twitter
Subscribe to Exits & Outcomes
Brian Dolan: Twitter | LinkedIn
HealthXL: Website | Twitter | Join an Event
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Digital Health Today is made possible by the support of our sponsors. Thank you to:
Bayer G4A
Cedars-Sinai Accelerator
Takeda
Roche
